Nature's Sunshine Products, Inc. (NATR)

Market Cap	441.19M +66.4%
Revenue (ttm)	480.14M +5.7%
Net Income	19.52M +153.7%
EPS	1.06 +165.0%
Shares Out	17.51M
PE Ratio	23.77
Forward PE	24.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	223,222
Open	24.55
Previous Close	24.76
Day's Range	23.82 - 25.94
52-Week Range	11.01 - 28.14
Beta	0.87
Analysts	Strong Buy
Price Target	28.33 (+12.42%)
Earnings Date	Mar 10, 2026

About NATR

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate in...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1972
• Employees: 806
• Stock Exchange: NASDAQ
• Ticker Symbol: NATR
• Website: https://www.naturessunshine.com

Financial Performance

In 2025, NATR's revenue was $480.14 million, an increase of 5.67% compared to the previous year's $454.36 million. Earnings were $19.52 million, an increase of 153.65%.

Analyst Summary

According to 3 analysts, the average rating for NATR stock is "Strong Buy." The 12-month stock price target is $28.33, which is an increase of 12.42% from the latest price.

Price Target

$28.33

(12.42% upside)

Analyst Consensus: Strong Buy